Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lipitor/Atorvastin Calcium Tablets
Company:  Parke-Davis Pharmaceutical Research
Application No.:  20702/S003/S005
Approval Date:  7/10/1998


Date created: March 08, 2001; last update: July 5, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.